Status:
COMPLETED
The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
Lead Sponsor:
Mary M. Gooley Hemophilia Center
Conditions:
vonWillebrand Disease
Hemophilia
Eligibility:
FEMALE
8-60 years
Phase:
NA
Brief Summary
The high percentage of failure using available non-surgical options to treat menorrhagia in women with bleeding disorders shows a continuing need for innovative treatments. This has led to development...
Detailed Description
Women with heavy periods and with a diagnosed bleeding disorders are prescribed cyclokapron pills to be taken during their periods. Their periods are assessed at 3 and 6 months by filling out a pictor...
Eligibility Criteria
Inclusion
- all menstruating women regardless of age
- Women with heavy periods as measured by pictorial blood assessment chart
- Women diagnosed with a bleeding disorder
Exclusion
- Acquired defective color vision
- Factor VIII, Factor IX, FactorXI levels \>250%
- An inherited thrombophilic defect detected because of a positive family or personal history of thrombosis
- Current use of oral contraceptives
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00697385
Start Date
April 1 2003
End Date
June 1 2008
Last Update
September 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mary M. Gooley Hemophilia Center
Rochester, New York, United States, 14621